期刊文献+

CD133在AC133阳性脑胶质瘤干细胞分化中的表达 被引量:3

Expression of CD133 during differentiation of AC133 positive glioma stem cells
原文传递
导出
摘要 目的探讨CD133mRNA及蛋白表达与胶质瘤细胞未分化状态的相关性。方法对富含AC133表达的胶质瘤干细胞进行了2周诱导分化,实时荧光定量聚合酶链反应(PCR)检测分化前后CD133mRNA表达,Westernblot法检测CD133总蛋白表达,流式细胞学检测细胞表面及细胞内AC133蛋白表达,酶联免疫吸附试验(ELISA)检测培养基上清中AC133蛋白的表达。结果AC133表达随胶质瘤干细胞分化出现显著下调(P〈0.05),CD133mRNA定量表达在NCH421k干细胞中分化前为1.08±0.39,血清环境下分化为1.08±0.51,血清+1μmol/L全反式维甲酸(ATRA)分化下为1.07±0.54,差异无统计学意义(P〉0.05),在NCH441干细胞中分别为2.61±1.72、2.534±1.18、2.18±1.73,差异也无统计学意义(P〉0.05)。CD133总蛋白表达在分化前后无显著改变。结论细胞表面AC133是相对于CD133mRNA及蛋白,能够更敏感地反映胶质瘤细胞未分化状态的指标。 Objective To explore the correlation between the expression of CD133 and undifferen- tiated state of glioma cells. Methods Differentiation was induced for 2 weeks in glioma stem cells en- riched with AC133 expression. Real-time quantitative polymerase chain reaction (PCR) was performed to study CD133 mRNA expression. Western blotting was used to detect the CD133 protein expression. By u- sing flow cytometry, extracellular and intracellular AC133 expression was examined. Enzyme linked immu- nosorbent assay (ELISA) was applied to measure the AC133 expression in the culture supernatant. Results The extraceliular AC133 expression in glioma stem cells was significantly down-regulated upon differentia- tion (P〈 0. 05 ). Quantitative CD133 mRNA expression in NCH421k cells before differentiation was 1.08 -+ 0. 39, 1.08 -+ 0. 51 in serum upon differentiation, and 1.07 -+ 0. 54 in serum plus 1 bLmol/L all- trans retinoic acid (P 〉0. 05), and that in NCH441 cells was 2. 61 -+ 1.72, 2. 53 -+ 1.18 and 2. 18 -+ 1.73 respectively (P 〉 0. 05). No significant difference in the CD133 protein expression was observed before and after differentiation. Conclusion Extracelluar AC133 more sensitively mirrors undifferentiated state of glioma cells than CD133 mRNA and protein.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第9期1667-1670,共4页 Chinese Journal of Experimental Surgery
关键词 CD133 AC133 胶质瘤 脑肿瘤干细胞 分化 CD133 AC133 Glioma Brain tumor stem cell Differentiation
  • 相关文献

参考文献8

  • 1雷霆,万锋.进一步研究脑肿瘤干细胞调节机制及其应用[J].中华实验外科杂志,2010,27(10):1373-1374. 被引量:11
  • 2Sgambato A,Puglisi MA, Errico F, et al. Post-translational modulation of CD133 expression (luring sodium butyrate-indueed differentiation of HT29 human colon cancer (:ells: implications for its detection. J Cell Physio1,2010 ,224 :234-241.
  • 3张所军,胡峰,谢蕊繁,王宝峰,叶飞,万锋,郭东生,雷霆.胶质瘤干细胞趋化神经干细胞迁移及其机制研究[J].中华实验外科杂志,2011,28(9):1412-1415. 被引量:6
  • 4冀保卫,田道锋,陈谦学,易伟,吴立权,沈恒.脑胶质瘤干细胞的培养和鉴定[J].中华实验外科杂志,2009,26(11):1525-1525. 被引量:2
  • 5Campos B, Wan F, Farhadi M, et al. Differentiation therapy exerts anti- tumor effects on stern-like glioma cells. Clin Cancer Res,2010, 16: 2715-2728.
  • 6Kemper K,Sprick MR,de Bree M,et al. The AC133 epitope,but rml tile CDI33 protein,is lost upon cancer stern cell differentiation. Cancer Res ,2010,70:719-729.
  • 7Rtiper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol,2000,2 : 582-592.
  • 8Beier D,Hau P,Proeseholdt M,et a1, CD133(+) and CD133(-) glioblastoma-derived cancer stem (:ells show differential growth charac- teristics and molecular profiles. Cancer Res,2007 ,67 :4010-4015.

二级参考文献8

共引文献16

同被引文献21

  • 1Jackson B, Brocker C, Thompson DC, et al. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum Genomics, 2011,5 : 283 -303.
  • 2Rasper M, Schafer A, Piontek G, et al. Aldehyde dehydrogenase 1 pos- itive glioblastoma cells show brain tumor stem cell capacity. Neuro On- col ,2010,12 : 1024-1033.
  • 3Ozbek E, Calik G, Otunctemur A, et al. Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer. Arch Ital Urol Androl,2012 ,84 :7-11.
  • 4Su Y, Qiu Q, Zhang X, et al. Aldehyde dehydrogenase 1 Al-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Bionmrkers Prey, 2010,19:327-337.
  • 5Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res,2009,7: 330-338.
  • 6Huang Z,Wu Q,Guryanova OA,et al.Deubiquitinase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells[J].Nat Cell Bio1,2011,13 (2):142-152.
  • 7Sullivan JP,Minna JD,Shay JW.Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation,progression,and targeted therapy[J].Cancer Metastasis Rev,2010,29 (1):61-72.
  • 8Zhou J,Zhang Y.Preclinical development of cancer stem cell drugs[J].Expert Opin Drug Discov,2009,4(7):741-752.
  • 9Bray SJ.Notch sigualing:a simple pathway becomes complex[J].Nat Rev Mol Cell Biol,2006,7(9):678-689.
  • 10Baba T,Convery PA,Matsumura N,et al.Epigenetic regulation of CD133 and tumorigenicity of CD133 + ovarian cancer cells[J].Oncogene,2009,28 (2):209-218.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部